Originally published In Press as doi:10.1074/jbc.M908025199 on March 29, 2000
J. Biol. Chem., Vol. 275, Issue 23, 17863-17868, June 9, 2000
A Single C-terminal Peptide Segment Mediates Both Membrane
Association and Localization of Lysyl Hydroxylase in the Endoplasmic
Reticulum*
Marko
Suokas
§,
Raili
Myllylä§, and
Sakari
Kellokumpu
§¶
From the
Department of Anatomy and Cell Biology,
University of Oulu, PL 5000, FIN-90401 Oulu, Finland and the
§ Department of Biochemistry, University of Oulu, Linnanmaa,
FIN-90570 Oulu, Finland
Received for publication, October 4, 1999, and in revised form, February 18, 2000
 |
ABSTRACT |
Hydroxylation of lysyl residues is crucial for
the unique glycosylation pattern found in collagens and for the
mechanical strength of fully assembled extracellular collagen fibers.
Hydroxylation is catalyzed in the lumen of the endoplasmic reticulum
(ER) by a specific enzyme, lysyl hydroxylase (LH). The absence of the known ER-specific retrieval motifs in its primary structure and its
association with the ER membranes in vivo have suggested
that the enzyme is localized in the ER via a novel retention/retrieval mechanism. We have identified here a 40-amino acid C-terminal peptide
segment of LH that is able to convert cathepsin D, normally a soluble
lysosomal protease, into a membrane-associated protein. The same
segment also markedly slows down the transport of the reporter protein
from the ER into post-ER compartments, as assessed by our pulse-chase
experiments. The retardation efficiency mediated by this C-terminal
peptide segment is comparable with that of the intact LH but lower than
that of the KDEL receptor-based retrieval mechanism. Within this
40-amino acid segment, the first 25 amino acids appear to be the most
crucial ones in terms of membrane association and ER localization,
because the last 15 C-terminal amino acids did not possess substantial
retardation activity alone. Our findings thus define a short peptide
segment very close to the extreme C terminus of LH as the only
necessary determinant both for its membrane association and
localization in the ER.
 |
INTRODUCTION |
Endoplasmic reticulum
(ER)1 is a heterologous
organelle containing large amounts of newly synthesized polypeptides as
well as resident proteins responsible for numerous post-translational modifications including glycosylation, folding, and oligomerization reactions. Because of their abundance, ER-resident proteins must be
efficiently segregated from their substrates by specific retention and/or retrieval signals in their primary structure.
To date, only two systems, both based on a retrieval mechanism, have
been characterized (for reviews see Refs. 1 and 2). The KDEL
tetrapeptide at the extreme C terminus is a common signal for a number
of luminal chaperones (3). The mechanism is based on the KDEL receptor
(erd2), which binds the escaped proteins in the Golgi complex and
returns them back to the ER (4, 5). Double lysine and presumably double
arginine motifs located in the cytoplasmic domains of several ER
membrane proteins also function as retrieval motifs (6, 7). It is known
that dilysine motif-containing proteins bind the complex of cytosolic
coat proteins (coatomer), COP I, and that this interaction mediates the
retrieval of these proteins from the Golgi back to the ER (8).
Sequences flanking the dilysine motif also contribute to the
steady-state distribution of the proteins between the ER and the Golgi
complex (6, 9).
Lysyl hydroxylase (EC 1.14.11.4, procollagen-lysine, 2-oxoglutarate
5-dioxygenase) is an enzyme in the lumen of the ER that catalyzes the
hydroxylation of lysyl residues in collagenous sequences (for reviews
see Refs. 10 and 11). Unlike most other luminal proteins in the ER,
lysyl hydroxylase (LH) does not contain either the KDEL sequence or any
of its close homologues in its primary structure (12). In addition, we
have previously shown that LH is associated with the ER membranes
in vivo and that this interaction involves mainly
electrostatic interactions (13). Therefore, it is likely that membrane
association is responsible for the localization of LH in the ER. If
this were indeed the case, membrane association would represent a
potentially novel mechanism by which luminal proteins may be localized
in the ER. As a first step to define the mechanism that is responsible
for the localization of LH in the ER, we have identified here a
C-terminal peptide segment in LH that, when tagged into a reporter
protein, is able to mediate both its membrane association and
localization in the ER. Thus this peptide segment by itself appears to
be sufficient for the correct localization of LH in the ER.
 |
MATERIALS AND METHODS |
Plasmids--
Plasmids CDM and CDMK encoding human cathepsin D
tagged either with a c-Myc-derived epitope (CDM) or c-Myc-SEKDEL (CDMK)
were kindly provided by Dr. Hugh Pelham (Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK). The CDMK plasmid was
used for preparing reporter protein constructs that contained short
sequences from LH. First, the SEKDEL sequence of the CDMK was replaced
with the sequence encoding the last 40 C-terminal amino acids (CDLH40)
of human lysyl hydroxylase isoform 1 (12). The region encoding the 40 C-terminal amino acids was amplified by polymerase chain reaction using
the following oligonucleotide primers
5'-CCGGAATTCGATCCGAGCCCCAAGGAAGG-3' and
5'-CTAGTCTAGATTAGGGATCGACGAAGGAGA-3'. The amplified product was
then cloned into the CDMK plasmid using EcoRI and
XbaI restriction sites. The whole coding region of cathepsin D including the 40 amino acids from LH was further subcloned into the
pCDNA3 mammalian expression vector (Invitrogen), containing the
cytomegalovirus promoter. CDLH15 construct containing only the last 15 C-terminal amino acids of LH was prepared accordingly, with the
exception that the corresponding amino acid region was prepared by
annealing two complementary oligonucleotides
5'-AATTCGACCACCAGGGGCACCCGCTA-CATCGAGTCTCCTTCGTCGATCC-3' and
5'-CTAGGGATCGACGAAGGAGACTGCGATGTAGCGGGTGCCCCTGGTGGTCG-3'. The annealed
fragment was cloned into the CDMK plasmid using EcoRI and
XbaI restriction sites.
For generating the plasmid that encodes the full-length lysyl
hydroxylase tagged with a c-Myc epitope (LHMyc), the coding region of
LH was first amplified, using the oligonucleotide primers 5'-CGCGGATCCATGCGGCCCCTGCTGCTA-3' and
5'-AGGCCTGGCCAAGAATTCGGGATCGACGAA-3', and then cloned into the
PCDNA3 vector using BamHI and EcoRI
restriction sites. The c-Myc epitope was inserted by annealing
complementary oligonucleotides,
5'-AATTCGAGCAAAAGCTCATTTCTGAAGAGGACTTGTGAT-3' and
5'-CTAGATCACAAGTCCTCTTCAGAAATGAGCTTTTGCTCG-3', followed by cloning of the annealed fragment into the C terminus using
EcoRI and XbaI restriction sites to allow
visualization with a monoclonal antibody 9E10 (Roche Molecular
Biochemicals or Santa Cruz). All amplified sequences were confirmed by
automatic sequencing using the ABI PRISMTM AmpliTaq FS dye terminator
cycle sequencing kit (Perkin-Elmer) and an ABI Prism 377 DNA sequencer.
Cell Culture and Transfections--
COS-7 cells were grown in
Dulbecco's modified Eagle's medium (Life Technologies, Inc.)
supplemented with Glutamax, 10% fetal bovine serum, and
penicillin-streptomycin. Cells were routinely plated on 35-mm Petri
dishes 1 day before transfections. Transfections were made using
FUGENE6TM transfection reagent (Roche Molecular Biochemicals). 2 µg
of plasmid DNA were used with 5 µl of transfection reagent, according
to the manufacturer's instructions. Protein expression was routinely
analyzed 40 h after transfection unless otherwise indicated.
Immunofluorescence Staining--
Cells were fixed with 4%
para-formaldehyde. All subsequent incubations were carried
out in the presence of saponin, as described earlier (14). Expressed
proteins were visualized using a monoclonal antibody, 9E10, followed by
Texas Red-conjugated anti-mouse secondary antibody (Amersham Pharmacia
Biotech). Stained specimens were examined using a Leitz CLSM confocal
microscope (Leica Laser Technics, Heidelberg, Germany).
Metabolic Labeling and Immunoprecipitation--
For pulse-chase
experiments, cells were first starved for 15 min in
methionine/cysteine-free medium supplemented with 1% fetal bovine
serum and then cultivated for 2 h in the presence of 200 µCi/ml
of Pro-mixTM cell labeling reagent (Amersham Pharmacia Biotech). Labeled cells were washed briefly and then chased for 3 h in
culture medium containing an excess of unlabeled methionine, 25 µg/ml cycloheximide, and 10 mM NH4Cl. Pulse-chase
experiments performed with the cells expressing LHMyc protein were done
without NH4Cl in chase medium.
The culture medium was collected, and cells were lysed in RIPA buffer
(50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton
X-100, 0.5% deoxycholate, 0.1% SDS), containing aprotinin,
phenylmethylsulfonyl fluoride, and EDTA as protease inhibitors.
Immunoprecipitations from the media and cell lysates were performed
with agarose-conjugated 9E10 antibody. Beads were washed with RIPA
buffer, and bound proteins were eluted with Laemmli's sample buffer.
Immunoprecipitates were analyzed by SDS-PAGE and, after fixation, the
gel was treated with EN3HANCE (DuPont) and exposed to x-ray
film (Fuji RS). The cell lysate:medium ratios of the different reporter
protein constructs were calculated after quantitation of the protein
bands with a computer-assisted image analysis program (MCID-M4, Imaging
Research, St. Catharines, Canada).
Electron Microscopy--
Electron microscopy was performed as
described earlier, with slight modifications (14, 15). Briefly, 24 h after transfection, cells were treated for 4 h with the calcium
ionophore A23187 (Calbiochem) in serum-free medium and then fixed with
2% para-formaldehyde, 0.1% glutaraldehyde (in
phosphate-buffered saline). Fixed cells were processed for
immunostaining with the 9E10 antibody and peroxidase-conjugated anti-mouse secondary antibodies using conventional procedures. Stained
specimens were examined using a Philips CM 100 transmission electron
microscope with an acceleration voltage of 60 kV.
Fractionation of Soluble and Membrane Proteins and
Immunoblotting--
Transfected cells were washed and scraped into TKM
buffer (50 mM Tris, 1 mM MgCl2, 10 mM KCl, pH 7.4). Cells were disrupted by brief sonication
(four times for 5 s) on ice. Cell membranes and supernatants were
separated by centrifugation (100,000 × g, 30 min). The
membrane fraction was solubilized directly in Laemmli's sample buffer.
Soluble proteins were recovered from the supernatant by
TCA-precipitation and solubilized in SDS sample buffer. Equivalent amounts of both fractions were subjected to SDS-PAGE and transferred to
a nitrocellulose membrane. Immunoblotting was performed with a
monoclonal antibody against protein disulfide isomerase (16) and with
the 9E10 monoclonal antibody, followed by peroxidase-conjugated anti-mouse antibodies (Biosys, Compiegne, France). Immunoreactive proteins were visualized using the ECL system (Amersham Pharmacia Biotech).
 |
RESULTS |
The C-terminal Peptide Segment of LH Slows the Transport of
Cathepsin D out of the ER--
The reporter protein constructs used in
this work are illustrated in Fig. 1. All
constructs are based on the CDM plasmid that we used as a reference
plasmid for measuring the normal transport rate of the reporter protein
itself. The plasmid encodes human cathepsin D tagged with a 10-amino
acid c-Myc epitope that is recognized by the monoclonal antibody 9E10
(17). Cathepsin D is a lysosomal aspartic protease that is routed to
the lysosomes via the mannose-6-phosphate receptor mediated pathway
(18). Previous studies have shown that the c-Myc epitope does not alter the intracellular routing of cathepsin D. The epitope appears, however,
to be cleaved during the maturation of the cathepsin D in lysosomes
(19, 20). The CDMK plasmid differs from the CDM plasmid in that the
SEKDEL sequence has been added to the C terminus of cathepsin D. Because the SEKDEL motif induces a well known and efficient retrieval
of cathepsin D from the Golgi back to the ER (19), this plasmid serves
as a control plasmid for a known ER-specific retrieval mechanism.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of the cathepsin D
constructs. Plasmids CDM and CDMK (19) were kindly provided by Dr
Hugh Pelham (Cambridge, UK). All constructs share the same backbone,
including the coding region of human cathepsin D extended with a short
c-Myc epitope (amino acids 410-419, human c-Myc protein). CDMK
contains an additional C-terminal hexapeptide SEKDEL. CDLH15 and CDLH40
contain sequences derived from the C terminus of human lysyl
hydroxylase isoform 1 (12). Numbers below the single-letter
amino acid codes correspond to the numbering of the lysyl hydroxylase
sequence.
|
|
ER-specific retrieval signals are characteristically found at the C
termini of proteins. Therefore, we also focused our first efforts to
the C terminus of LH. We constructed two different cathepsin D
constructs, one that contains the last 15 C-terminal amino acids
(CDLH15) of LH and the other one that contains 25 additional amino
acids toward the N terminus of LH (CDLH40), thus consisting altogether
of the last 40 C-terminal amino acids of LH (Fig. 1). All protein
constructs (CDM, CDMK, CDLH15, and CDLH40) were then transiently
expressed in COS-7 cells, and the chimeric proteins were localized with
the antibody 9E10. Indirect immunofluorescence showed that both the CDM
(Fig. 2A) and the CDLH15 (Fig.
2C) protein were localized predominantly in the perinuclear
region, suggestive of their transient accumulation in the Golgi complex
during their transport into-post Golgi compartments. Staining of the ER
was also evident in some cells, as assessed by double staining with an
antibody against protein disulfide isomerase. In contrast, CDMK (Fig.
2B) and CDLH40 (Fig. 2D) protein constructs
accumulated mainly in fine reticular structures throughout the
cytoplasm. The staining pattern was typical of that of the ER, and this
was confirmed by double staining with an anti-PDI antibody (data not shown). In a proportion of cells, the CDLH40 protein was also present
in the Golgi region, in addition to the ER.

View larger version (106K):
[in this window]
[in a new window]
|
Fig. 2.
Subcellular distribution of cathepsin D
constructs in transfected COS-7 cells. Transfections with CDM
(A) or CDLH15 (C) plasmids and subsequent
staining with the monoclonal antibody 9E10 show the accumulation of
these reporter proteins in the perinuclear region, typical of an
association with the Golgi complex. In contrast, cells transfected with
CDMK (B) or CDLH40 (D) plasmids show a typical
reticular ER staining pattern.
|
|
To evaluate the retardation efficiency of the different protein
constructs, we next performed pulse-chase analyses on transfected cells. We labeled the cells with radioactive methionine for 2 h
and chased them for 3 h in the presence of ammonium chloride. Ammonium chloride is known to dissipate endogenous targeting of cathepsin D to lysosomes and leads to its secretion into the medium (20, 21). However, when cathepsin D is expressed as a recombinant protein, a nearly equal amount of the protein is secreted into the
medium without the drug treatment. To quantitate the retardation efficiency of the different cathepsin D protein constructs, we measured
their relative amounts in the medium and inside the cells by
immunoprecipitation. When the cells were transfected with either CDM or
CDLH15 plasmids (Fig. 3), about 80% of
the immunoprecipitated proteins were found in the medium. These results
indicated that both of these two chimeric proteins were efficiently
secreted from the cells, as was also suggested by our
immunofluorescence data (Fig. 2).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 3.
Secretion of different reporter protein
constructs in transfected cells. A, transfected cells
were labeled with [35S]Met/Cys for 2 h and
subsequently chased for 3 h in medium containing 10 mM
NH4Cl. Proteins were recovered from the cells (lanes
C) or from the medium (lanes M) by immunoprecipitation
with agarose-conjugated 9E10 antibody. Bound proteins were resolved by
SDS-PAGE and analyzed by autoradiography. Minor bands below
the major protein product probably represent degradation products,
which were not included for the calculation of the retardation
efficiencies. B, quantitation of the proportions of
intracellular and secreted proteins in transfected cells. Note that in
experiments with CDM or CDLH15, most of the reporter protein was
detected in the medium, whereas in cells transfected with CDMK or
CDLH40, the reporter protein was retained intracellularly.
|
|
In contrast, the KDEL-tagged cathepsin D (CDMK plasmid) was efficiently
retained inside the cells, and only negligible amounts of the protein
were found in the medium (Fig. 3). Similarly, the CDLH40 protein (Fig.
3) was also mostly retained inside the transfected cells (in the ER;
Fig. 2), and about 75% of the protein was generally recovered from the
cells, the rest being found in the medium. Similar results were also
obtained in the absence of ammonium chloride. Both of these protein
constructs (CDMK and CDLH40) were also found to undergo autocatalysis
under low pH conditions (22) and to bind to immobilized pepstatin A (an
active site inhibitor for cathepsin D), indicating that their
retardation was not due to their incorrect folding and association with
the quality control machinery. Collectively, the above results show
that the C terminus of LH indeed contains substantial retardation
activity. This activity, however, does not seem to reside in the very
extreme C terminus of LH, because the CDLH15 construct was efficiently
secreted from the transfected cells.
The Full-length LH Is Also Partially Secreted from the Transfected
Cells--
For comparative reasons, we next transfected cells with the
LHMyc plasmid that encodes the full-length LH tagged with the C-terminal c-Myc epitope. Staining of transfected cells with the monoclonal 9E10 antibody revealed that the protein accumulated in the
ER, as expected (Fig. 4A).
Western blotting of total cell lysates from transfected cells with the
9E10 antibody confirmed the expression of a double band with the
expected size of both the nonglycosylated (80 kDa) and glycosylated (87 kDa) forms of LH (Fig. 4B). The expressed full-length LH
protein was also found to be enzymatically active, as judged by the
hydroxylation-coupled decarboxylation of
2-oxo[1-14C]glutarate (23).

View larger version (90K):
[in this window]
[in a new window]
|
Fig. 4.
Expression of the full-length lysyl
hydroxylase in COS cells. A, localization of the
expressed LHMyc protein after staining with 9E10 antibody. Note the
accumulation of LHMyc protein in the ER. B, Western blot
analysis using 9E10 antibody of proteins from cells expressing LHMyc.
According to their size, the 87- and 80-kDa bands detected by the
antibody probably represent glycosylated and unglycosylated forms of
LH, respectively. C, pulse-chase experiments of the LHMyc
shows that the majority of the LHMyc protein is found in the cell
lysate (lane C), but a substantial portion (both the 87- and
80-kDa bands) is also secreted into the medium (lane
M).
|
|
Pulse-chase experiments (Fig. 4C) performed as above (at
40 h after the transfection) showed that most (85-90%) of the
expressed c-Myc-tagged LH protein was recovered from the cells.
Nevertheless, 10-15% of the full-length LH was also secreted into the
medium during the 3-h chase. Thus, the retardation efficiencies of the full-length LH protein and the CDLH40 protein constructs were rather
comparable with each other. The CDLH40 construct thus appears to
contain most of the information needed for the correct localization of
the full-length LH in the ER. The retardation efficiency of the
KDEL-tagged cathepsin D was clearly highest of the protein constructs tested.
CDLH40 Protein Associates with the ER Membranes--
Previously,
we have shown that the full-length LH is associated in vivo
with the ER membranes (13). To test whether the 40-amino acid segment
of the LH can also convert cathepsin D into a membrane-associated
protein, we fractionated transfected cells into membrane and soluble
fractions and followed the distribution of the chimeric proteins in the
two fractions by SDS-PAGE and immunoblotting. Both the full-length LH
(LHMyc) and CDLH40 protein construct were found to co-sediment almost
exclusively with the cellular membranes (Fig.
5A). Only negligible amounts
of either protein were recovered from the membrane-depleted fractions.
Thus, the 40-amino acid peptide segment of LH is, indeed, able to
mediate the association of cathepsin D with the ER membranes. In
contrast, endogenous PDI (a KDEL-containing protein) was recovered
mainly in the soluble fractions (
70%). The CDMK protein, which we
used as an additional control protein, was equally distributed between the two fractions (Fig. 5A). The reason for the membrane
association of the CDMK protein is not known, but it may be due to its
interaction with the KDEL receptor, which has been shown to
redistribute into the ER when KDEL-containing proteins are
overexpressed (5).

View larger version (105K):
[in this window]
[in a new window]
|
Fig. 5.
Membrane association of the CDLH40
protein. A, cells expressing CDLH40, CDMK, or LHMyc
protein were fractionated into membrane (lanes M) and
soluble (lanes S) fractions. The distribution of the
reporter proteins and PDI between the two fractions was analyzed using
9E10 and anti-PDI antibodies. Both the CDLH40 and LHMyc protein
constructs were found almost exclusively in the membrane fraction, in
contrast to PDI, which was recovered mostly in the soluble fraction.
CDMK protein was distributed equally to both fractions. B,
an electron micrograph showing A23187-treated cells expressing the
CDLH40 protein. Note the peroxidase-precipitate along with the ER
membranes. For comparison, endogenous PDI and procollagen are localized
throughout the ER lumen in the drug-treated fibroblasts (15).
er, endoplasmic reticulum; m, mitochondria;
n, nucleus.
|
|
We next processed transfected cells for immunoelectron microscopy after
staining the chimeric protein with the 9E10 antibody followed by
peroxidase-conjugated secondary antibody. To allow better visualization
of the expressed protein within the ER lumen, a calcium ionophore,
A23187, was used to induce the dilatation of the ER cisternae before
fixation of the cells (15). Electron microscopy (Fig. 5B)
confirmed the expected association of the CDLH40 protein with the ER
membranes. Thus, both our biochemical and immunohistochemical data
indicate that the 40-amino acid C-terminal segment alone is able to
mediate the association of the reporter protein with the ER membranes.
 |
DISCUSSION |
Among a vast number of the luminal proteins of the ER, LH protein
has two unique features, namely the absence of known ER-specific retention/retrieval signals and its association in vivo with
the ER membranes. In this report, we have localized a short peptide segment in the C terminus of LH that alone was sufficient both for the
localization of cathepsin D in the ER and for its association with the
ER membranes. The 40-amino acid C-terminal peptide segment of LH
therefore appears to possess all the necessary information needed to
localize endogenous LH in the ER membranes. The retardation did not
result from aberrant folding of the reporter protein and its putative
association with the ER quality control machinery, because the enzyme
retained its autocatalytic properties in vitro and also
bound to its active site inhibitor, pepstatin A.
By using two overlapping constructs (CDLH40 and CDLH15) in which the
last 15 C-terminal amino acids are common, we were able to show that
only the CDLH40 protein was efficiently retained in the ER in the
transfected cells, whereas the CDLH15 construct (cathepsin D tagged
with the last 15 C-terminal amino acids) was readily transported out of
the ER and could be recovered from the medium in pulse-chase
experiments. The most crucial portion of this 40-amino acid segment
both for the membrane association and ER localization appears therefore
to be buried within the first 25 amino acids (amino acids 688-712 of
LH1 isoform) of this 40-amino acid segment. This portion contains few
positively charged amino acids, which may directly mediate the
association of LH with the membranes (14). According to the sequence
data, this region and the whole 40-amino acid segment are also nearly
identical between different species and also very homologous (
90%)
to recently cloned other two human and mouse LH isoforms (24-27).
Conservation of this C-terminal segment suggests that other LH isoforms
may use the same region for their localization in the ER. Our data, however, do not exclude the possibility that the last 15 amino acids
may also contribute to the retardation efficiency of the CDLH40
construct, although alone (CDLH15) they did not have substantial retardation activity.
Our findings, showing that membrane association and ER localization are
strictly coupled phenomena, provide the first direct evidence for the
view (13) that the membrane association is responsible for the
localization of the enzyme in the ER. Membrane association therefore
raises important questions about the identity of the membrane
counterpart(s) with which LH and the identified peptide segment
associates in vivo. One possibility is that LH could
associate with the ER membranes by interacting directly with membrane
phospholipids. For example, a number of cytoplasmic proteins that
possess plekstrin homology domains associate with the membranes by
binding to phospatidylinositol phosphates (28). However, according to
sequence analyses (SMART version 3.0 or E-MOTIF), no such a motif is
present in the full-length LH protein sequence or in the 40-amino acid
C-terminal segment. Another possibility for the membrane association of
LH is a carbohydrate-mediated retention of incompletely folded proteins
with the quality control machinery (29). Although the full-length LH is
N-glycosylated, the C-terminal peptide segment does not
contain any potential N-linked glycosylation sites,
suggesting that its membrane association does not involve
asparagine-linked carbohydrate structures.
The most likely possibility, therefore, is that LH associates with the
ER membranes via specific protein-protein interactions. This is also
supported by our preliminary molecular sizing experiments, in which we
have found that about half of the full-length, c-Myc-tagged LH is
solubilized from the cells as a high molecular weight complex. The
large size of the complex excludes putative interactions with the ER
membrane phospholipids. In this respect, it is interesting to note that
prolyl-4-hydroxylase, a heterotetrameric
(
2
2) collagen processing enzyme, is
localized in the ER via its
-subunit, protein disulfide isomerase
(30), which is a well known KDEL-containing protein. However, because
this protein complex is not membrane-associated (Fig. 5 and Ref. 13), a
different kind of interaction appears to be responsible for the
membrane association and localization of LH in the ER. Other known
proteins, which associate with the ER membranes, include
e.g. inositol 1,4,5-trisphosphate 3-kinase (31), and
tyrosine phosphatase PTP-1B (32). The association of the former also
likely involves specific protein-protein interactions (31), whereas the
association type of the latter is not known. Both proteins, however,
are found on the cytoplasmic side of the ER membranes.
The retardation efficiency mediated by the C-terminal peptide segment
(CDLH40) and of the full-length LH itself (LHMyc) were shown to be
lower than that of the KDEL-containing CDMK construct under similar
experimental conditions. Because both the LHMyc and the CDLH40 protein
constructs were secreted from the cells to some extent (10-15% and
20-25%, respectively), the retention machinery responsible for the
localization of the LH protein constructs seems to be more easily
saturable than that of the KDEL-receptor mediated retrieval mechanism.
This suggestion is consistent with the known expression levels of the
endogenous proteins in vivo. The KDEL-containing chaperones
and folding enzymes are generally known as the most abundant proteins
in the ER lumen, whereas LH is expressed at a much lower level in
tissues and cells studied thus far (33). Thus, there is no need for a
highly efficient retention/retrieval system for LH in the ER lumen. The
suggestion is also supported by the observed differences in the amount
of the secreted, but not intracellular, CDLH40 protein with
transfection time, being 15, 25, and 50% at 24, 40, and 48 h
after the transfection, respectively.2 The difference
in the rate of secretion between the two LH constructs (LHMyc and
CDLH40) may also result from their differential expression levels in
the transfected cells. For some unknown reason, the LHMyc construct
appears to be expressed consistently at lower levels in COS-7 cells
during transient transfections. The difference in the secretion could
also be due to small conformational differences that may exist within
the C-terminal peptide segment between the Myc-tagged full-length LH
and the CDLH40 construct. We did not attempt to increase the
retardation efficiency of the CDLH40 protein, e.g. by
extending the length of the C-terminal segment toward the N terminus of
LH because of the presence of nearby cysteine residues, which have been
shown to act as signals for the quality control machinery (20, 34).
As a conclusion, we report here the identification of a 40-amino acid
peptide segment in the C terminus of LH that alone is sufficient to
convert otherwise a soluble lysosomal protein, cathepsin D, into an ER
membrane-associated protein. Within this peptide segment, the first 25 amino acids appeared to be the most crucial ones in terms of ER
localization. The retardation efficiency mediated by this 40-amino acid
segment was comparable with that of the c-Myc-tagged full-length LH,
especially if their expression levels in the transfected cells are
taken into account. The 40-amino acid segment appears therefore to
contain all the necessary information for the correct localization of
the endogenous LH in the ER as well. The maximal retardation
efficiencies of the LH protein constructs were, however, lower than
that of the KDEL-receptor mediated retrieval mechanism. Thus, both the
steady-state membrane association and low capacity/saturability appear
to be the hallmarks of this novel type of retention/retrieval mechanism.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Hugh R. Pelham for providing the
basic cathepsin D constructs and Dr. Raija Sormunen for help with the
electron microscopy. We also thank Sirpa Kellokumpu, Paula Soininen,
and Eero Oja for expert technical assistance.
 |
FOOTNOTES |
*
This work was supported by grants from the Academy of
Finland and Sigrid Juselius Foundation, Finland.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Biochemistry, University of Oulu, PL 5000, FIN-90401 Oulu, Finland.
Tel.: 358-8-5531148; Fax: 358-8-5531141; E-mail:
sakari.kellokumpu@oulu.fi.
Published, JBC Papers in Press, March 29, 2000, DOI 10.1074/jbc.M908025199
2
M. Suokas, R. Myllylä, and S. Kellokumpu, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
LH, lysyl hydroxylase;
PDI, protein disulfide isomerase;
PAGE, polyacrylamide gel electrophoresis.
 |
REFERENCES |
| 1.
|
Teasdale, R. D.,
and Jackson, M. R.
(1996)
Annu. Rev. Cell Dev. Biol.
12,
27-54
|
| 2.
|
Pelham, H. R.
(1991)
Curr. Opin. Cell Biol.
4,
585-591
|
| 3.
|
Munro, S.,
and Pelham, H. R.
(1987)
Cell
48,
899-907
|
| 4.
|
Lewis, M. J.,
and Pelham, H. R.
(1990)
Nature
348,
162-163
|
| 5.
|
Lewis, M. J.,
and Pelham, H. R.
(1992)
Cell
68,
353-364
|
| 6.
|
Jackson, M. R.,
Nilsson, T.,
and Peterson, P. A.
(1993)
J. Cell Biol.
121,
317-333
|
| 7.
|
Letourneur, F.,
Gaynor, E. C.,
Hennecke, S.,
De-Molliere, C.,
Duden, R.,
Emr, S. D.,
Riezman, H.,
and Cosson, P.
(1994)
Cell
79,
1199-1207
|
| 8.
|
Schutze, M. P.,
Peterson, P. A.,
and Jackson, M. R.
(1994)
EMBO J.
13,
1696-1705
|
| 9.
|
Itin, C.,
Schindler, R.,
and Hauri, H. P.
(1995)
J. Cell Biol.
131,
57-67
|
| 10.
|
Kivirikko, K. I.,
Myllylä, R.,
and Pihlajaniemi, T.
(1992)
in
Post-translational Modifications of Proteins
(Harding, J. J.
, and Crabbe, M. J., eds)
, pp. 1-51, CRC Press, Boca Raton, FL
|
| 11.
|
Prockop, D. J.,
and Kivirikko, K. I.
(1995)
Annu. Rev. Biochem.
64,
403-434
|
| 12.
|
Hautala, T.,
Byers, M. G.,
Eddy, R. L.,
Shows, T. B.,
Kivirikko, K. I.,
and Myllylä, R.
(1992)
Genomics
13,
62-69
|
| 13.
|
Kellokumpu, S.,
Sormunen, R.,
Heikkinen, J.,
and Myllylä, R.
(1994)
J. Biol. Chem.
269,
30524-30529
|
| 14.
|
Kellokumpu, S.,
Neff, L.,
Jämsä-Kellokumpu, S.,
Kopito, R.,
and Baron, R.
(1988)
Science
242,
1308-1311
|
| 15.
|
Kellokumpu, S.,
Suokas, M.,
Risteli, L.,
and Myllylä, R.
(1997)
J. Biol. Chem.
272,
2770-2777
|
| 16.
|
Höyhtyä, M.,
Myllylä, R.,
Piuva, J.,
Kivirikko, K. I.,
and Tryggvason, K.
(1984)
Eur. J. Biochem.
141,
477-482
|
| 17.
|
Evan, G. I.,
Lewis, G. K.,
Ramsay, G.,
and Bishop, J. M.
(1985)
Mol. Cell. Biol.
5,
3610-3616
|
| 18.
|
Kornfeld, S.
(1992)
Annu. Rev. Biochem.
61,
307-330
|
| 19.
|
Pelham, H. R.
(1988)
EMBO J.
7,
913-918
|
| 20.
|
Fra, A. M.,
Fagioli, C.,
Finazzi, D.,
Sitia, R.,
and Alberini, C.
(1993)
EMBO J.
12,
4755-4761
|
| 21.
|
Braulke, T.,
Geuze, H. J.,
Slot, J. W.,
Hasilik, A.,
and von Figura, K.
(1987)
Eur. J. Cell Biol.
43,
316-321
|
| 22.
|
Zhu, Y.,
and Conner, G. E.
(1994)
J. Biol. Chem.
269,
3846-3851
|
| 23.
|
Kivirikko, K. I.,
and Myllylä, R.
(1982)
Methods Enzymol.
82,
245-304
|
| 24.
|
Valtavaara, M.,
Papponen, H.,
Pirttilä, A.-M.,
Hiltunen, K.,
Helander, H.,
and Myllylä, R.
(1997)
J. Biol. Chem.
272,
6831-6834
|
| 25.
|
Valtavaara, M.,
Szpirer, C.,
Szpirer, J.,
and Myllylä, R.
(1998)
J. Biol. Chem.
273,
12881-12886
|
| 26.
|
Passoja, K.,
Rautavuoma, K.,
Ala-Kokko, L.,
Kosonen, T.,
and Kivirikko, K. I.
(1998)
Proc. Natl. Acad. Sci.
95,
10482-10486
|
| 27.
|
Ruotsalainen, H.,
Sipilä, L.,
Kerkelä, E.,
Pospiech, H.,
and Myllylä, R.
(1999)
Matrix Biol.
18,
325-329
|
| 28.
|
Shaw, G.
(1996)
BioEssays
1,
35-46
|
| 29.
|
Parodi, A. J.
(1999)
Biochim. Biophys. Acta
1426,
287-295
|
| 30.
|
Vuori, K.,
Pihlajaniemi, T.,
Myllylä, R.,
and Kivirikko, K. I.
(1992)
EMBO J.
11,
4213-4217
|
| 31.
|
Soriano, S.,
Thomas, S.,
High, S.,
Griffiths, G.,
D'Santos, C.,
Cullen, P.,
and Banting, G.
(1997)
Biochem J.
324,
579-589
|
| 32.
|
Frangioni, J. V.,
Beahm, P. H.,
Shifrin, V.,
Jost, C. A.,
and Neel, B. G.
(1992)
Cell
68,
545-560
|
| 33.
|
Heikkinen, J.,
Hautala, T.,
Kivirikko, K. I.,
and Myllylä, R.
(1994)
Genomics
24,
464-471
|
| 34.
|
Isidoro, C.,
Maggioni, C.,
Demoz, M.,
Pizzagalli, A.,
Fra, A. M.,
and Sitia, R.
(1996)
J. Biol. Chem.
271,
26138-26142
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Kokkonen, A. Rivinoja, A. Kauppila, M. Suokas, I. Kellokumpu, and S. Kellokumpu
Defective Acidification of Intracellular Organelles Results in Aberrant Secretion of Cathepsin D in Cancer Cells
J. Biol. Chem.,
September 17, 2004;
279(38):
39982 - 39988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Stefanovic, L. Stefanovic, B. Schnabl, R. Bataller, and D. A. Brenner
TRAM2 Protein Interacts with Endoplasmic Reticulum Ca2+ Pump Serca2b and Is Necessary for Collagen Type I Synthesis
Mol. Cell. Biol.,
February 15, 2004;
24(4):
1758 - 1768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Stefanovic and D. A. Brenner
5' Stem-Loop of Collagen alpha 1(I) mRNA Inhibits Translation in Vitro but Is Required for Triple Helical Collagen Synthesis in Vivo
J. Biol. Chem.,
January 3, 2003;
278(2):
927 - 933.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.